Citations for: Foster, R. H.; Wilde, M. I. Dienogest. Drugs 1998, 56 (5), 825–833.

Entry Type
Name
Value
Parent Entry
Pharmacology Data Field
Agonist. Some antagonist behavior.
Dienogest (API)
Pharmacology Data Field
Antagonist (40% of CPA, the most potent anti-androgenic progestin)
Dienogest (API)
Pharmacology Data Field
Weak or no agonist and antagonist activity
Dienogest (API)
Pharmacology Data Field
Low to no activity
Dienogest (API)
Pharmacology Data Field
No activity
Dienogest (API)
Pharmacology Data Field
90-96.2%
Dienogest (API)
Pharmacology Data Field
8-10 h
Dienogest (API)
Toxicology Data Field
In COCs with ethinyl estradiol: irregular vaginal bleeding, headache, breast pain, nausea/vomiting, depression, decreased libido
Dienogest (API)
Pharmacology Data Field
90% bound to serum albumin, 10% free. No binding to SHBG or CBG.
Dienogest (API)
Pharmacology Data Field
Mainly via kidneys.
Dienogest (API)
Pharmacology Data Field
40 L from 2 mg/day oral dose
Dienogest (API)
Pharmacology Data Field
2 h
Dienogest (API)
Pharmacology Data Field
Oettel: 4.0 ng/mL
Foster: 1 mg/day oral dose for inhibition of ovulation in cyclical women
Dienogest (API)
Metabolites
N/A